Danielle Ternyila
Advertisement
Articles by Danielle Ternyila
Advertisement
Latest Updated Articles
Disease Recurrence Similar Between Tamoxifen, Anastrozole in Postmenopausal Women With DCISPublished: December 10th 2020 | Updated:
Frontline Lenvatinib/Everolimus Combo Is Active in Non-Clear Cell RCCPublished: November 6th 2020 | Updated:
CELMoD CC-92480/Dexamethasone Combo Shows Early Activity in Relapsed/Refractory MyelomaPublished: December 6th 2020 | Updated:
Higher Dose of CPX-351 Linked With Prolonged Hematologic Recovery in AMLPublished: December 9th 2020 | Updated:
Selinexor/Daratumumab Combo Shows Promise in Relapsed/Refractory MyelomaPublished: January 22nd 2019 | Updated:
Following Progression on CAR T-Cell Therapy, B-Cell Lymphoma Treatment Options NeededPublished: February 12th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5